Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 1
1952 2
1953 4
1954 3
1955 1
1956 2
1957 2
1958 2
1959 1
1960 3
1961 2
1966 1
1970 1
1971 3
1993 1
1996 3
1997 3
1998 6
1999 3
2000 7
2001 6
2002 6
2003 9
2004 7
2005 12
2006 8
2007 9
2008 5
2009 7
2010 6
2011 4
2012 5
2013 5
2014 4
2015 8
2016 8
2017 5
2018 5
2019 2
2020 2
2021 4
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.
Kario K, Yokoi Y, Okamura K, Fujihara M, Ogoyama Y, Yamamoto E, Urata H, Cho JM, Kim CJ, Choi SH, Shinohara K, Mukai Y, Ikemoto T, Nakamura M, Seki S, Matoba S, Shibata Y, Sugawara S, Yumoto K, Tamura K, Yoshihara F, Nakamura S, Kang WC, Shibasaki T, Dote K, Yokoi H, Matsuo A, Fujita H, Takahashi T, Kang HJ, Sakata Y, Horie K, Inoue N, Sasaki KI, Ueno T, Tomita H, Morino Y, Nojima Y, Kim CJ, Matsumoto T, Kai H, Nanto S. Kario K, et al. Among authors: yoshihara f. Hypertens Res. 2022 Feb;45(2):221-231. doi: 10.1038/s41440-021-00754-7. Epub 2021 Oct 15. Hypertens Res. 2022. PMID: 34654905 Free PMC article. Clinical Trial.
Cardioprotective effect of adrenomedullin in heart failure.
Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H. Nishikimi T, et al. Among authors: yoshihara f. Hypertens Res. 2003 Feb;26 Suppl:S121-7. doi: 10.1291/hypres.26.s121. Hypertens Res. 2003. PMID: 12630822 Free article. Review.
[Adrenomedullin].
Yoshihara F. Yoshihara F. Nihon Rinsho. 2006 Jul;64 Suppl 5:122-6. Nihon Rinsho. 2006. PMID: 16897857 Review. Japanese. No abstract available.
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. Yoshihara F, et al. EClinicalMedicine. 2023 Nov 27;66:102334. doi: 10.1016/j.eclinm.2023.102334. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38192595 Free PMC article.
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).
Doi Y, Shinzawa M, Arisato T, Oka H, Matsumoto A, Kitamura H, Nakazono Y, Nishiya Y, Ueda Y, Kamimura T, Hayashi T, Yoshihara F, Isaka Y. Doi Y, et al. Among authors: yoshihara f. Clin Exp Nephrol. 2024 Feb 25. doi: 10.1007/s10157-024-02467-w. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38402502
176 results